National Comprehensive Cancer Network

Educational Events & Programs

NCCN Academy for Excellence & Leadership in Oncology™
School of Pharmaceutical & Biotech Business

Tuesday, July 14, 2015
8:20 AM – 2:15 PM
(Breakfast and registration begin at 7:30 AM)

The Rittenhouse Hotel
Philadelphia, PA



Pharmaceutical and biotechnology professionals are given the rare opportunity to view the oncology space, its future and its current operational issues from the provider and payer perspective. Participants will improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology and will gather valuable insights material to developing effective strategies for navigating the various constituencies in cancer care. Through this interactive program, pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships.

Professionals from marketing, sales, medical affairs, clinical research, policy and government affairs, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.

Please check back often for additional updates regarding this program. If you have any questions, please contact Jennifer Tredwell, Senior Director, Marketing.


Clifford Goodman, PhD
Senior Vice President
The Lewin Group


7:30 – 8:15 AM
Breakfast and Registration

8:20 – 8:25 AM
C. Lyn Fitzgerald, MJ
Vice President, U.S & Global Development
National Comprehensive Cancer Network

8:30 – 10:00 AM
Module I: New Trends in Utilization Management Strategies
for Systemic Therapies and Diagnostics

Dane Dickson, MD
Chief Executive Officer,
Molecular Evidence Development Consortium (Med-C)

Matthew Farber, MA
Senior Director, Oncology Disease State
Walgreen Co.

John Fox, MD, MHA
Associate Vice President of Medical Affairs
Priority Health

Elaine Jeter, MD
MolDx Medical Director
Palmetto GBA

Steve Miller, MD
Senior Vice President and Chief Medical Officer
Express Scripts

10:00 – 10:10 AM

10:15 – 11:55 AM
Module II: Improving Patient Engagement; Using Technology to Support the Navigation and Delivery of Quality Cancer Care
Invited Panelists:
Loreen Brown, MSW
Senior Vice President of Product Management and Not-for-Profit Operations
Lash Group, AmerisourceBergen

Gabriel Eichler, PhD
General Manager, Client Services & Strategic Initiatives
Patients Like Me

Matthew Farber, MA
Senior Director, Oncology Disease State
Walgreen Co.

Jeffrey Pollard, MD
Director of Medical Affairs
23 and Me

Mark Redlus
Senior Vice President of Labs and Innovation
Polaris Health Directions

Ronald S. Walters, MD, MBA, MHA, MS
Associate VP of Medical Operations & Informatics
Professor, Breast Medical Oncology
The University of Texas MD Anderson Cancer Center

12:00 – 12:45 PM

12:45 – 2:05 PM
Module III: Meet the NCCN Guidelines Experts; Melanoma, Multiple Myeloma, Myeloid Growth Factors, Non-Hodgkin’s Lymphomas
Kenneth C. Anderson, MD (Multiple Myeloma)
Kraft Family Professor of Medicine, Harvard Medical School
Director, LeBow Institute for Myeloma Therapeutics
Director, Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute

Robert W. Carlson, MD
Chief Executive Officer,
National Comprehensive Cancer Network

Jeffrey Crawford, MD (Myeloid Growth Factors)
George Barth Geller Professor for Research in Cancer
CoDirector, Solid Tumor Therapeutics Program,
Duke Cancer Institute

Michael Deininger, MD, PhD (CML)
Chief, Division of Hematology and Hematologic Malignancies
M.M. Wintrobe Professor of Medicine
Huntsman Cancer Institute at the University of Utah

Leo I. Gordon, MD (Non-Hodgkin’s Lymphomas)
Abby & John Friend Professor of Cancer Research, Professor in Medicine Director, Lymphoma Program
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Anthony J. Olszanski, RPh, MD (Melanoma)
Associate Professor, Director, Early Clinical Drug Development
Therapeutics/Phase I Program
Co-Director, Melanoma Program
Fox Chase Cancer Center

2:05 – 2:15 PM
Closing Remarks         
Gary J. Weyhmuller, MBA, SPHR
Executive Vice President, Chief Operating Officer
National Comprehensive Cancer Network

*Subject to change.

Program Location:

The Rittenhouse Hotel
210 West Rittenhouse Square
Philadelphia, Pennsylvania 19103

Tuition Information:

Academy Alumni$895
Industry Registrants$1,295
NCCN Corporate Council Members$1,195
Ten or more people from the same company$1,050



We currently have a room block for the night of Monday, July 13, 2015. Attendees may book a room by calling Rittenhouse Hotel Reservations at 1.800.635.1042. Please be sure to state that you are attending NCCN Academy.

A discounted rate of $249 has been negotiated for NCCN attendees. Please book your room by Friday, June 12, 2015 to receive the discounted rate. Early booking is strongly recommended.

License NCCN Academy Video Modules!

Permission licenses are available to purchase exclusive video footage of recent NCCN Academy for Excellence & Leadership in Oncology&trade School of Pharmaceutical & Biotech Business programs for viewing by internal company representatives for one year.

Customize your own NCCN Academy curriculum.

NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests.

Approximately 97 percent of recent NCCN Academy attendees say they would attend an NCCN Academy program again or recommend that colleagues attend.